Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease

J Transl Med. 2024 Jun 13;22(1):566. doi: 10.1186/s12967-024-05348-8.
No abstract available

Publication types

  • Published Erratum